AT WHAT COST?

Since 2015, the $40 billion of annual NIH spending has been one of the American people’s smartest investments — saving millions of lives, creating millions of jobs, and producing hundreds of billions of dollars in economic prosperity.

Data from NIH REPORTER as of 4/7/25. Future awards projected by reducing average awards from 2015-2024 by 27%.

In just the last decade, NIH funding has meant:

Last year congress appropriated funding for NIH to continue this investment in critical, livesaving research. So far this year, the Trump administration has been holding over a quarter of this funding hostage. As of April 7th, the NIH has failed to spend $1,700,000,000 towards external research grants,  a 27% decrease compared to 2015-2024. These cuts are already jeopardizing breakthroughs in cancer and chronic disease treatment, as clinical trials close down and experiments stop. If this 27% decrease continues, it will mean a $8,100,000,000 cut in NIH research investment by the end of the year.

What’s the cost of a 27% cut in NIH spending?

  • $202,500,000,000 economic loss by 2035

  • 99,900 jobs lost each year

  • All 9000 clinical trials currently underway with NIH support are in danger

  • Hundreds fewer FDA-approved drugs over the next decade

  • Countless lives lost

Too many people confronting an aggressive cancer diagnosis or other deadly disease don’t have months or years to wait while funding is delayed – their only hope is advanced research now.